Table 1. The prevalence of NAFLD and NASH in patients with diabetes.

Study	Study population	Diagnostic methods	Categories	Prevalence, %
Mohan et al. (2009) [16]	In 132 Indian adults with diabetes	US	NAFLD	54.5
Kim et al. (2014) [17]	In 4,437 Korean patients with T2DM	US	NAFLD	72.7
Targher et al. (2007) [18]	In 2,839 Italian patients with T2DM	US	NAFLD	69.5
Portillo-Sanchez et al. (2015) [11]	In 103 American patients with diabetes with normal plasma aminotransferases	1H-MRS	NAFLD	50
Williams et al. (2011) [13]	In 54 biopsied patients with diabetes	Liver biopsy	NASH	22
Hyysalo et al. (2014) [12]	In 115 biopsied participants in in the Finnish population-based D2D-study	Liver biopsy	NASH	17.6
Kim et al. (2014) [15]	In 929 Korean patients with diabetes	US	NAFLD	63.3

US, ultrasonography; NAFLD, non-alcoholic fatty liver disease; ¹H-MRS, proton magnetic resonance spectroscopy; T2DM, type 2 diabetes mellitus; NASH, non-alcoholic steatohepatitis.